Method for treating hypocalcemia
AssigneeAllergan, Inc.
InventorStephen Donovan
Life of this patent
Estimating the term…
Abstract
A method for treating hypoparathyroidism and/or hypocalcemia by local administration of a neurotoxin, such as a botulinum toxin, to a parathyroid gland, thereby reducing an inhibitory effect upon parathyroid hormone secretion. A method for treating hyperparathyroidism and/or hypercalcemia by local administration of a neurotoxin, such as a botulinum toxin, to a sympathetic ganglion which innervates a parathyroid hormone secreting parathyroid cell, thereby reducing a stimulatory effect upon parathyroid hormone secretion.
Claims4
A method for treating hypocalcemia, the method comprising the step of local administration to a parathyroid gland of a therapeutically effective amount of a botulinum toxin, thereby increasing a parathyroid hormone secretion from a parathyroid cell and treating hypocalcemia.
A method for treating hypocalcemia, the method comprising the step of local administration to a parathyroid gland of a therapeutically effective amount of a botulinum toxin type A, thereby increasing a parathyroid hormone secretion from a parathyroid cell and treating hypocalcemia.
Dependencies are inferred from the claim text.